2024 SPRING

Senior Executive

Conference

Trends in Oncology

May 19-21, 2024

London, England

InterContinental London Park Lane

2024 SPRING

Senior Executive

Conference

May 19-21, 2024

London, England

InterContinental London Park Lane

Sign in with your ALDA account to register. Please contact us if you need assistance.

ALDA is heading across the pond for our 2024 Spring Senior Executive Conference. The meeting will bring together top industry leaders from around the globe. Our conferences provide a unique platform for networking, cover timely topics, and feature world-class speakers who offer strategic insights into trends, emerging technologies, and new markets.

ALDA’s semi-annual meetings are for presidents, CEOs, COOs, and senior executives from our member companies.

More details about the conference program and speakers will be announced soon. Stay tuned! All times are BST.

Saturday, May 18

5-9 p.m.
ALDA Member-hosted Networking Event at the London Zoo (Optional)

Hosted by the Zoological Society of London (ZSL) and sponsored by PEAK Scientific and Danaher.

Plan to come to London early as the Saturday before the conference, ALDA attendees will have exclusive access to the London Zoo, after hours, as the ZSL hosts ALDA for private tours behind the scenes, up-close interactions with the animals that aren’t available to the public, a networking reception featuring short presentations from chief scientists at the ZSL, and a networking buffet dinner.

    • Spouses and partners are welcome to attend.
    • The event is included in your conference registration.
    • Transportation will be provided to and from the conference host hotel, Intercontinental Park Lane.

Special thanks to ALDA members PEAK Scientific and Danaher for making this event happen.

Sunday, May 19

4-5:30 p.m.
Reception for Women Executives
The ALDA DEI Task Force will host a reception welcoming women executives to the conference. More details to come!

6-9:15 p.m.
Welcome reception and seated dinner with guest speaker:

Zanny Minton Beddoes

Editor-in-Chief of The Economist

A Future View: Global Leadership & Our Global Economy

Zanny Minton Beddoes is the Editor-in-Chief of The Economist, the first woman to hold the position in the history of the publication. Prior to this role, she was The Economist’s business affairs editor, economics editor, and emerging markets correspondent based in London. She has written surveys of the World Economy, Latin American finance, global finance and Central Asia. Ms. Minton Beddoes has written extensively about international financial issues including enlargement of the European Union, the future of the International Monetary Fund and economic reform in emerging economies. She is a regular television and radio commentator on BBC, MSNBC, PBS, NPR, CNN and CNBC.

Ms. Minton Beddoes will bring this breadth of knowledge and insight to ALDA attendees, sharing the latest developments in the global economy that will impact leaders at our member companies as well as her vision of the future and what it means for ALDA senior executives.

Monday, May 20

9 a.m. – 4:15 p.m.
“Trends in Oncology” programming. More speakers will be announced soon. All sessions will take place in the same room; several networking breaks are built into today’s schedule.

Genomics in Oncology: The Latest Developments & Potential of Precision Medicine & Early Detection

 

Dr. Nik-Zainal will share insights from her work and research at Cambridge and the Early Cancer Institute to shed light on the current state of cancer research in genomics, and how these new developments could lead to innovative, attainable, game-changing applications in precision medicine in the near future, and what that means for ALDA member companies.

Presented by:

Serena Nik-Zainal, MB, PhD
Professor of Genomic Medicine and Bioinformatics, University of Cambridge
Research Professor, National Institute of Health and Care Research

Innovations in Oncology Drug Discovery: Shaping Tomorrow’s Cancer Treatments

 

Dr. Zhang will share her work and perspectives on the future of drug discovery, innovative therapies, her organization’s commitment to transforming drug discovery for cancer care, and how it could impact ALDA members.

 

This session will provide a unique opportunity to delve into the next wave of technology innovation for the future of Oncology and understand how drug discovery innovation is shaping patient outcomes.

Presented by:

Litao Zhang, PhD
Global Head of Discovery Technologies & Molecular Pharmacology
Therapeutics Discovery, Johnson & Johnson Innovative Medicine

Digital Pathology: Advancements and Applications in Modern Oncology

 

Dr. Darren Treanor is a Consultant Pathologist at Leeds Teaching Hospitals NHS Trust and a Senior Clinical Lecturer at the University of Leeds. He is known for his work in digital pathology, focusing on the development and implementation of digital pathology systems to improve diagnostic efficiency and educational resources within the medical field.

 

He is also Guest Professor in Digital Pathology at Linköping University, Sweden, where he works with the university and hospital teams on digital pathology research in a well-established project where 100% of clinical slides are scanned. In his session, Dr. Treanor will share the latest developments in digital pathology as it relates to oncology, including work on a national digital pathology system for diagnosis using AI.

Presented by:

Darren Treanor MD, PhD
Director, National Pathology Imaging Co-operative
Consultant Pathologist in Liver and Gastrointestinal Pathology
, Leeds Teaching Hospitals NHS Trust
Honorary Clinical Professor of Pathology
, University of Leeds

Executive Panel: Transforming Oncology through Liquid Biopsy Innovations

 

In this enlightening panel session, attendees will have the unique opportunity to hear from senior executives of premier liquid biopsy companies. Liquid biopsy is transforming oncology by enabling earlier detection, personalized treatment strategies, and real-time monitoring of disease progression and response to treatment.

 

The session will explore the significant impact of liquid biopsy on current oncology trends and discuss its broader implications for executives in attendance, highlighting how these innovations are reshaping cancer care and research.

 

More panelists will be announced shortly. 

Panelist:

Panelist:

Mike Nolan
Chief Executive Officer, Freenome

Moderator:

Moderator:

Valerie Dixon
Managing Director, Healthcare Investment Banking Group
, Morgan Stanley

Tuesday, May 21

7-7:45 a.m.
Breakfast for Women Executives

The ALDA DEI Task Force will host an educational and informative breakfast for women executives in attendance, as the CEO of the London Stock Exchange, Julia Hoggett, will sit down for an informal moderated Q&A and take questions from the audience about navigating her career, managing her current position, and other lessons in leadership.

8-8:30 a.m.
The State of Capital Markets

Julia Hoggett
CEO, London Stock Exchange

Tuesday programming will kick off with a presentation by the CEO of the London Stock Exchange, Julia Hoggett, who will share the latest on the state of capital markets around the world, the economy in the UK, and the case for UK markets.

8:30-9:30 a.m.
Keynote session with guest speaker:

Siddhartha Mukherjee, MD

Siddhartha Mukherjee, a renowned oncologist, biologist, and Pulitzer Prize-winning author will serve as our distinguished closing speaker. Dr. Mukherjee’s groundbreaking work in cancer research and his profound insights into the cellular basis of cancer have positioned him as a pivotal figure in the field. His best-selling book, “The Emperor of All Maladies: A Biography of Cancer,” artfully blends scientific exploration with historical narrative, offering a deep and engaging perspective on the disease. Additionally, his more recent work, “The Gene: An Intimate History,” delves into the human genome, providing crucial insights that are highly relevant for cutting-edge cancer research and treatment.

Dr. Mukherjee will delve into the latest advancements in oncology, providing attendees with an opportunity to gain insights from one of the leading experts in the field. His focus on innovation in cancer treatment and diagnosis is sure to inform attendees on current trends and future directions in cancer research, while inspiring ideas for a collaborative approach to tackling these challenges in this rapidly evolving sector. Don’t miss this chance to learn from and interact with one of the luminaries in cancer research and treatment.

First attendee from your company:
$2,795

Additional attendees from your company:
$2,295

London, England
InterContinental London Park Lane
One Hamilton Place, Park Ln, London W1J 7QY, United Kingdom

Steeped in Royal heritage and standing proudly on the former site of 145 Piccadilly, the former childhood home of Queen Elizabeth II, there is no better place to experience all London has to offer. Surrounded by the elegant shops and restaurants of Mayfair and Knightsbridge, many of the hotel’s rooms have views across London’s Royal Parks.

Attendees must make their own hotel reservations. Please make your reservations using this Passkey link. Please be sure to click on and review the cancellation policies at the InterContinental London Park Lane when making your reservations.

Due to GDP regulations, the Intercontinental London Park Lane can not take payment details via phone, so you must make your reservation using the link. For any questions, or if you would like to add shoulder nights, you can call the reservation number +44 (0)20 74093131 or send an email to the hotel staff.

2024-spring-senior-executive-conference

What can I expect?

Opportunities to make powerful connections, gain valuable insights from world-class speakers, and inspiration from like-minded leaders.

When is the conference?

We begin on Sunday, May 19 at 6 p.m. with a business-oriented speaker and dinner. The conference wraps up with our keynote speaker on Tuesday, May 21 around 9:30 a.m.

Who should attend?

Presidents, CEOs, COOs and senior executives from ALDA member companies. Spouses are also welcome to attend the Sunday and Monday dinners and the closing session on May 21.

**This conference is for ALDA members only. If you are interested in attending and are a non-member, please contact ALDA staff regarding membership and the necessary next steps.

What is the cost to attend?

  • First attendee from your company: $2,795
  • Each additional attendee: $2,295

Where can I stay?

Attendees must make their own hotel reservations. ALDA has a room block available at the conference host hotel, The Intercontinental London Park Lane. Book your room here. Due to GDP regulations, the Intercontinental London Park Lane can not take payment details via phone, so you must make your reservation using the link. For any questions, or if you would like to add shoulder nights, you can call the reservation number +44 (0)20 74093131 or email the hotel staff.

How do I register?

  1. Sign in to the website with your username and password. If you’re a member, you can reset your password here, if needed. Or, please contact us for assistance signing in.
  2. To register only yourself, select “Add Me.” Click “Save/Continue” to proceed through registration.
  3. Group registration: to register more than one person from your company and use one payment method for all registrants, use “Add Someone Else” to search for records in our system. If any registrant is not in our system, you can add them. Once all registrants are added, click “Save/Continue” to proceed through registration.

I have more questions – who can I contact?

Please contact Carol Starke, ALDA Meetings and Administration Manager, via email.